rBCG-N-RSV Vaccine in Adults Aged 60 Years and Older

Clinical trial NCT07762014 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07762014
Sponsor: Biothervax SpA
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infection Prevention Tuberculosis Prevention

Start date: 2026-09-07
Primary completion: 2027-09-07
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.